基于CRISPR/Cas12a的双放大动态DNA网络系统用于p53基因检测
Tengkai Wang1, Kexin Ding2, Xinli Wang2
1Department of Gastroenterology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan, Shandong, 250012, China; Cheeloo College of Medicine, Shandong University, No. 44 Wenhua West Road, Jinan, Shandong, 250012, China.
Analytica chimica acta
|August 18, 2024
概括
这项研究引入了一种新的CRISPR/Cas系统,用于高度敏感的p53基因检测. 双放大策略提供了早期癌症诊断潜力,提高了准确性和轻度条件.
科学领域:
- 生物技术是生物技术.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 超过50%的人类癌症涉及p53基因突变.
- 早期检测p53基因对于及时诊断癌症至关重要.
- 现有的检测方法缺乏灵敏度,需要严格的条件.
研究的目的:
- 开发一种灵敏而准确的p53基因检测策略.
- 通过一种新的生物传感方法,使得早期癌症诊断成为可能.
- 克服传统p53检测技术的局限性.
主要方法:
- 利用了CRISPR/Cas系统与驱动催化 (EDC) 和杂化连锁反应 (CHA) 进行双信号放大.
- 使用CRISPR/Cas12a激活来显著增强光信号.
- 开发了一个动态的DNA网络,用于敏感的光生物传感.
主要成果:
- 从0.1 fM到0.5 pM实现了p53检测的优异线性.
- 为p53基因建立了0.096 fM的超低检测极限.
- 在血清样本中表现出有效的性能,表明早期疾病检测的潜力.
结论:
- 开发的双放大系统为p53基因识别提供了超敏感的光生物传感.
- 该方法很简单,在温和条件下使用单个缓冲器运行,并为各种标记器提供智能可设计性.
- 这项工作为开发用于疾病检测的敏感光生物传感器提供了有前途的工具.
相关概念视频
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
CRISPR/Cas9 Genome Editing
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...


